Sublingual Buprenorphine/Naloxone for Chronic Pain in At-Risk Patients: Development and Pilot Test of a Clinical Protocol

OBJECTIVE: Sublingual buprenorphine/naloxone (Bup/Nx) is approved for addiction treatment and may be useful for pain management, particularly in opioid-treated pain patients with nonadherence behaviors. The transition of opioid-treated pain patients to buprenorphine carries the risk of precipitated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rosenblum, Andrew, Cruciani, Ricardo A., Strain, Eric C, Cleland, Charles M., Joseph, Herman, Magura, Stephen, Marsch, Lisa A, McNicholas, Laura F, Savage, Seddon R, Sundaram, Arun, Portenoy, Russell K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3630795/
https://ncbi.nlm.nih.gov/pubmed/23264315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5055/jom.2012.0137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados